Since inflammation is known to be a significant contributor to the pathogenesis of cardiovascular disease, we studied the number and function of a novel subset of regulatory T cells, termed CD4+LAP+ Tregs, in patients with ACS. The gene discussed is TGFB1; the disease is cardiovascular disorder.